Skip to NavigationSkip to content

drug cost

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

Published on 27/04/15 at 01:26pm

YES - says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that blaming the pharma patent system for hepatitis C drugs’ prices is a non-starter.

New hepatitis C treatments have been a regular feature in healthcare news of late, not least because they offer that most elusive of gifts: a cure.

Over one billion drugs dispensed in England in 2014, NHS report shows

NHS image

Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures.

Statistics from the Health and Social Care Information Centre (HSCIC), which collates data on behalf of the NHS, show an increase of 3%, or 34 million items, on 2013.

The latest Prescription Cost Analysis reveals the Net Ingredient Cost (NIC, or the cost of a drug before discounts, and excluding dispensing costs or fees) in 2014 was £8.9 billion. This also increased by 3% (£227 million) compared with the year before. 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches